Leonard M. Greenstein, Chief Financial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 9,877 shares at $15.90 ($157K) on 2022-10-20, disclosed to the SEC on 2022-10-28.
Open-market sale of $157k TARS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.90 | 4,877 | $78K | 49.3% |
| 2 | $15.90 | 4,877 | $78K | 49.3% |
| 3 | $16.62 | 123 | $2K | 1.3% |
| Total | $15.91 avg | 9,877 | $157K | 100% |
| Filing → |
| TARS | SELL | 2023-03-21 | $8K | — | Filing → |
| TARS | SELL | 2023-03-17 | $71K | — | Filing → |
| TARS | SELL | 2023-02-17 | $76K | — | Filing → |